Literature DB >> 16003787

Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies.

John A Ormiston1, Mark W I Webster, Seifeddin El Jack, Peter N Ruygrok, James T Stewart, Douglas Scott, Erin Currie, Monique J Panther, Bronwyn Shaw, Barbara O'Shaughnessy.   

Abstract

The objective of this study was to bench-test provisional bifurcation stenting strategies to provide insights on how best to perform these with drug-eluting stents (DESs). Bifurcation stenting with DESs reduces restenosis compared with bare metal stents (BMSs). Outcomes with a single DES are better than with two DESs but if the main branch is stented, there needs to be a reliable strategy for provisionally stenting the side-branch with full ostial scaffolding and drug application. Stents were photographed in a phantom after deployment with different strategies. With provisional T-stenting, placement of the side-branch stent without gaps is difficult. The internal (or reverse) crush strategy fully scaffolds the side-branch ostium but is experimental. The culotte technique providing excellent side-branch ostial coverage is easier to perform with open-cell or large-cell stent design. In general, kissing balloon post-dilation improves stent expansion, especially at the ostium, and corrects distortion. However, a main-branch kissing balloon of smaller diameter than the deploying balloon causes distortion. Final main-branch postdilatation or sequential postdilatation prevents distortion after the internal crush strategy.

Entities:  

Mesh:

Year:  2006        PMID: 16003787     DOI: 10.1002/ccd.20453

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  15 in total

Review 1.  Prediction of protein function and pathways in the genome era.

Authors:  T Gabaldón; M A Huynen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

2.  Main branch stent deformation following difficult side branch rewiring and balloon dilatation. Rare complication of provisional T stenting.

Authors:  M Tomasevic; V Vukcevic; G Stankovic; D Orlic; M Ostojic
Journal:  Herz       Date:  2010-09-22       Impact factor: 1.443

Review 3.  Dedicated bifurcation stents.

Authors:  Ajith Ananthakrishna Pillai; Balachander Jayaraman
Journal:  Indian Heart J       Date:  2012-04-28

4.  New strategies in the treatment of coronary bifurcations.

Authors:  I Iakovou; N Foin; A Andreou; N Viceconte; C Di Mario
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

5.  A Pilot Study on Culottes versus Crossover Single Stenting for True Coronary Bifurcation Lesions.

Authors:  Linlin Zhang; Wenliang Zhong; Yukun Luo; Lianglong Chen
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

6.  Final kissing balloon inflation for coronary bifurcation lesions treated with single-stent technique : A meta-analysis.

Authors:  G Liu; X Ke; Z-B Huang; L-C Wang; Z-N Huang; Y Guo; M Long; X-X Liao
Journal:  Herz       Date:  2017-11-27       Impact factor: 1.443

7.  The Role of Bioresorbable Scaffolds in Meeting the Challenges of Bifurcations.

Authors:  Axel Schmermund; Holger Eggebrecht
Journal:  Interv Cardiol       Date:  2013-08

Review 8.  Stenting of coronary bifurcation lesions: a literature and technical review.

Authors:  Joo Myung Lee; Kyung Woo Park; Bon-Kwon Koo; Hyo-Soo Kim
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

9.  To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions.

Authors:  Giuseppe Biondi-Zoccai; Imad Sheiban; Stefano De Servi; Corrado Tamburino; Giuseppe Sangiorgi; Enrico Romagnoli
Journal:  Heart Vessels       Date:  2014-11       Impact factor: 2.037

10.  Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples.

Authors:  Stefan Kralev; Benjamin Haag; Jens Spannenberger; Siegfried Lang; Marc A Brockmann; Soenke Bartling; Alexander Marx; Karl-Konstantin Haase; Martin Borggrefe; Tim Süselbeck
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.